Simplex Trading’s Cytosorbents Corp CTSO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-5
| Closed | – | – | 9204 |
|
|
2025
Q2 | $0 | Buy |
+5
| New | +$100 | ﹤0.01% | 8805 |
|
|
2025
Q1 | – | Sell |
-16
| Closed | – | – | 8679 |
|
|
2024
Q4 | $0 | Buy |
+16
| New | +$314 | ﹤0.01% | 8674 |
|
|
2024
Q3 | – | Sell |
-1
| Closed | – | – | 8647 |
|
|
2024
Q2 | $0 | Sell |
1
-30
| -97% | -$520 | ﹤0.01% | 8937 |
|
|
2024
Q1 | $0 | Sell |
31
-42
| -58% | -$818 | ﹤0.01% | 8992 |
|
|
2023
Q4 | $1K | Buy |
73
+15
| +26% | +$446 | ﹤0.01% | 8456 |
|
|
2023
Q3 | $2K | Sell |
58
-1,271
| -96% | -$73K | ﹤0.01% | 8060 |
|
|
2023
Q2 | $95K | Buy |
1,329
+102
| +8% | +$6.45K | ﹤0.01% | 5143 |
|
|
2023
Q1 | $82K | Buy |
1,227
+1,183
| +2,689% | +$71K | ﹤0.01% | 5378 |
|
|
2022
Q4 | $1K | Buy |
44
+30
| +214% | +$890 | ﹤0.01% | 8787 |
|
|
2022
Q3 | $0 | Sell |
14
-8
| -36% | -$312 | ﹤0.01% | 10039 |
|
|
2022
Q2 | $0 | Sell |
22
-394
| -95% | -$18.1K | ﹤0.01% | 10115 |
|
|
2022
Q1 | $26K | Buy |
416
+292
| +235% | +$20.9K | ﹤0.01% | 7927 |
|
|
2021
Q4 | $10K | Sell |
124
-614
| -83% | -$68.9K | ﹤0.01% | 9009 |
|
|
2021
Q3 | $111K | Buy |
738
+40
| +6% | +$6.5K | ﹤0.01% | 6465 |
|
|
2021
Q2 | $105K | Buy |
+698
| New | +$118K | ﹤0.01% | 6657 |
|
|
2020
Q4 | – | Sell |
-158
| Closed | -$26.4K | – | 8439 |
|
|
2020
Q3 | $25K | Sell |
158
-458
| -74% | -$82.6K | ﹤0.01% | 6207 |
|
|
2020
Q2 | $122K | Buy |
+616
| New | +$113K | ﹤0.01% | 4585 |
|
|
2020
Q1 | – | Sell |
-55
| Closed | -$5.55K | – | 7688 |
|
|
2019
Q4 | $4K | Buy |
55
+11
| +25% | +$960 | ﹤0.01% | 6755 |
|
|
2019
Q3 | $4K | Sell |
44
-85
| -66% | -$9.9K | ﹤0.01% | 6681 |
|
|
2019
Q2 | $17K | Buy |
129
+58
| +82% | +$7.97K | ﹤0.01% | 5732 |
|
|
2019
Q1 | $10K | Buy |
71
+58
| +446% | +$9.03K | ﹤0.01% | 6144 |
|
|
2018
Q4 | $2K | Sell |
13
-572
| -98% | -$114K | ﹤0.01% | 6545 |
|
|
2018
Q3 | $150K | Sell |
585
-109
| -16% | -$27.3K | ﹤0.01% | 3971 |
|
|
2018
Q2 | $158K | Buy |
+694
| New | +$131K | ﹤0.01% | 3761 |
|
|
2017
Q2 | – | Sell |
-11
| Closed | -$965 | – | 6193 |
|
|
2017
Q1 | $1K | Sell |
11
-453
| -98% | -$50.6K | ﹤0.01% | 5588 |
|
|
2016
Q4 | $50K | Buy |
+464
| New | +$50.8K | ﹤0.01% | 2154 |
|
|
2016
Q3 | – | Sell |
-588
| Closed | -$61.1K | – | 5878 |
|
|
2016
Q2 | $53K | Buy |
588
+51
| +9% | +$4.44K | ﹤0.01% | 1994 |
|
|
2016
Q1 | $42K | Buy |
537
+342
| +175% | +$29.7K | ﹤0.01% | 2101 |
|
|
2015
Q4 | $21K | Buy |
195
+156
| +400% | +$21.2K | ﹤0.01% | 2634 |
|
|
2015
Q3 | $4K | Buy |
+39
| New | +$5.2K | ﹤0.01% | 4130 |
|
|
2015
Q2 | – | Sell |
-132
| Closed | -$18K | – | 5280 |
|
|
2015
Q1 | $34K | Buy |
+132
| New | +$27.2K | ﹤0.01% | 1854 |
|
Other funds holding CTSO
CM
Simplex Trading's CTSO Position: Q3 2025 in Review
Simplex Trading sold out of Cytosorbents Corp (CTSO) in Q3 2025, closing a stake of 5 shares.
Simplex Trading first reported a position in CTSO in Q1 2015 and held it in 31 quarters. The position peaked at $158K in Q2 2018. 48 funds tracked by Wall St. Rank hold CTSO as of Q3 2025.
- Simplex Trading reported no remaining Cytosorbents Corp position as of Q3 2025 after selling out during the quarter.
- Simplex Trading sold 5 Cytosorbents Corp shares in Q3 2025.
- Simplex Trading first reported a position in Cytosorbents Corp in Q1 2015 and held it in 31 quarters.
- Simplex Trading's Cytosorbents Corp position peaked at $158K in Q2 2018.
- 48 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q3 2025.
Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.